Activation of p53 upon DNA damage induces an array of target genes, leading to cell cycle arrest and/or apoptosis. However, the mechanism by which the cell fate is controlled by p53 remains to be clarified. Previously, we showed that DEC1, a basic helix-loophelix transcription factor and a target of p53, is capable of inducing cell cycle arrest and mediating DNA damage-induced premature senescence. Here, we found that ectopic expression of DEC1 inhibits, whereas knockdown of DEC1 enhances, DNA damage-induced cell death. Surprisingly, we showed that the anti-cell-death activity of DEC1 is p53 dependent, but DEC1 does not directly modulate p53 expression. Instead, we showed that DEC1 inhibits the ability of p53 to induce macrophage inhibitory cytokine-1 (MIC-1), but not other prosurvival/proapoptotic targets, including p21 and Puma. Importantly, we showed that upon binding to their respective response elements on the MIC-1 promoter, DEC1 and p53 physically interact on the MIC-1 promoter via the basic helix-loop-helix domain in DEC1 and the tetramerization domain in p53, which likely weakens the DNA-binding activity of p53 to the MIC-1 promoter. Finally, we found that depletion of MIC-1 abrogates the ability of DEC1 to attenuate DNA damage-induced cell death. Together, we hypothesize that DEC1 controls the response of p53-dependent cell survival vs. cell death to a stress signal through MIC-1.Stimulated by retinoic acid 13 | growth differentiation factor 15 I n response to genotoxic stress, p53 is activated, leading to induction of cell death regulators, such as Puma, Bax, FDXR, and PolH, and cell survival regulators, such as p21, Mdm2, 14-3-3σ, and GADD45 (1-3). However, a central puzzle is how p53 determines the cell fate in response to a specific stimulus. Previously, we and others have shown that the expression level and functional domains of p53 are involved in the cell fate determination (4-7) as well as several cofactors that alter the ability of p53 to transcriptionally regulate its targets. For examples, the ASPP family proteins (8), p53β (9), and p90 (10) preferentially affect p53 to regulate proapoptotic targets, such as Bax, but not p21. Conversely, BRCA1 (11) and HZF (12) cooperate with p53 to transactivate p21 but not Bax. Interestingly, hCAS/CSE1L is able to selectively affect a set of p53 targets and p53-dependent apoptosis without directly binding to p53 (13).DEC1 belongs to a subfamily of basic helix-loop-helix (bHLH) transcription factors and is a critical regulator of the circadian rhythm (14). DEC1 is defined as a senescence marker because it is up-regulated in premalignant tumors (15). Consistent with this, our previous studies showed that DEC1 is a target of the p53 family and mediates G1 cell cycle arrest and DNA damage-induced premature senescence (16,17). Evidence also showed that DEC1 plays a role in cell death. For examples, overexpression of DEC1 inhibits serum starvation-induced apoptosis in HEK293 cells (18), and DEC1 mediates TGF-β-induced cell survival in breast cancer cells (19). H...